Cart
sales@molnova.com
AU-224
CAS No. 287399-47-7
AU-224( —— )
Catalog No. M33244 CAS No. 287399-47-7
AU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 411 | In Stock |
|
| 10MG | 562 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAU-224
-
NoteResearch use only, not for human use.
-
Brief DescriptionAU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.
-
DescriptionAU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
-
In Vitro——
-
In VivoAU-224 has excellent effect of promoting digestive motion while showing little side effect and can be orally administered. AU-224 shows only weak gastrointestinal prokinetic activity after oral administration due to its low lipophilicity.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number287399-47-7
-
Formula Weight397.9
-
Molecular FormulaC19H28ClN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCCCC)CN1CCC(NC(=O)C=2C=C(Cl)C(N)=CC2OC)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WO/2000/046201A1
molnova catalog
related products
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
-
Fmoc-N-Me-Leu-OH
Fmoc-N-Me-Leu-OH, an N-Fmoc-N-methyl amino acid, is available for the peptide-coupling reaction.
-
SMIFH2
SMIFH2 is formin homology 2 (FH2) domains inhibitor.
